Netpharm Consulting ApS: Financial statements 2025
CVR: 41104554
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Netpharm Consulting ApS (CVR 41104554) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365. The solvency ratio was 100%.
- Gross Profit
- DKK -18,341
- Profit/Loss
- DKK -18,341
- Equity
- DKK 15,365
- Total Assets
- DKK 15,365
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -18K | -18K | 15K | - |
| 2024 | - | -14K | -14K | 34K | 0 |
| 2023 | - | -20K | -20K | 48K | - |
| 2022 | - | - | -10K | 68K | - |
| 2021 | 153K | 200 | 200 | 78K | - |
Official annual report
How creditworthy is Netpharm Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Netpharm Consulting ApS has published its annual report for 2024. Gross profit came to DKK -14,288, and the net result was DKK -14,288.
About Netpharm Consulting ApS
Netpharm Consulting ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Byong Sandersen. The company is owned by Netpharm Holding ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,341 and a net result of DKK -18,341 compared with DKK -14,288 the year before. Equity in the 2025 report amounted to DKK 15,365.